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1682-606X/Copyright ª 2016, Taiwan
CC BY-NC-ND license (http://creativSummary A 34-year-old male patient presented with seizure and was finally diagnosed with
intracerebral hematoma because of dural arteriovenous fistula bleeding. Acute onset of hemi-
plegia developed after 9 days of endovascular therapy. Angiography confirmed venous throm-
bosis.
Copyright ª 2016, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Intracranial dural arteriovenous fistula (DAVF) cases usually
present with hemorrhage and neurological deficits at thehave no conflicts of interest
of Neurosurgery, Shin Kong




ecommons.org/licenses/by-nc-ndtime of diagnosis. Endovascular therapy is one of the
treatment options. Cerebral venous thrombosis (CVT) is one
of the most serious complications associated with endo-
vascular techniques. Delayed cerebral venous infarction is a
rare complication in the literature.2. Case Report
A 34-year-old male presented with complex partial
seizure. Brain computed tomography (CT), CT angiography
(CTA) (Figure 1) and magnetic resonance imaging revealedby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Figure 1 (A) Brain CT shows left parietal ICH; (B) and (C) brain CTA; (D), (E) and (F) SWI. Multiple surrounding engorged vessels
are revealed.
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engorged vessels in the left parietal region. Subsequent
digital subtraction angiography (DSA, Figure 2) confirmed a
Cognard type III DAVF. The DAVF was embolized with Onyx
from the left occipital artery through the external carotid
artery. Angiography after transarterial embolization (TAE)
revealed complete obliteration of the lesion and no oc-
clusion of any other arterial or venous structures. Head-
ache and confusion developed 6 hours after embolization
and repeat brain CT (Figure 3C) showed progressive left
parietal hematoma with marked perifocal edema and
adjacent congested vein. Osmotic agent therapy with
mannitol improved his symptoms. Nine days after endo-
vascular therapy, acute onset of right hemiplegia devel-
oped. Brain CT (Figure 3D) findings were consistent with
left frontal-parietal infarction and brain herniation. DSA
(Figures 3E and 3F) confirmed left transverse sinus to
sigmoid sinus thrombosis. Revascularization with endo-
vascular angioplasty and thrombolysis were attempted but
failed. Emergent left decompressive craniectomy and
hematoma evacuation were performed. The patient
continued to have right upper-limb weakness after the
operation. His disseminated intravascular coagulation
profile was checked on the first day after surgery. Fibrin-
ogen, D-dimer, and fibrin degradation product levels were
elevated; protein S and antithrombin were reduced,
whereas platelet count, global clotting times (i.e., acti-
vated partial thromboplastin time and prothrombin time),
and protein C were within normal range. Only the proteinS was persistently low; the other test results were unre-
markable on repeated laboratory studies 2 weeks after
surgery.3. Discussion
The vein of Labbe´ and sigmoid sinus of the patient were
patent before and immediately post-TAE of the DAVF.
Consciousness disturbance after the endovascular therapy
with new hematoma could be explained by the compromise
of the cortical draining vein because of previous hematoma
enlargement with perifocal edema. Although osmotherapy
improved the initial post-TAE brain edema in our patient, it
simultaneously created dehydration status and potentiated
the development of silent CVT over 9 days post-TAE. Other
than dehydration status, our patient also had risk factors
for CVT such as coagulation disorders and hematological
conditions. Protein S deficiency was noted on the follow-up
laboratory test. Redistribution of the venous drainage
pathways and subsequent venous hypertension were sug-
gested as causing the pathophysiological change. However,
extensive collateral circulation within the cerebral venous
system enables a considerable degree of compensation in
the early stages of venous occlusion.1 This insidious process
of CVT could lead clinicians to delay diagnosis. In addition,
patients with CVT always present with syndromes clinically
indistinguishable from isolated headache and intracranial
hypertension.2
Figure 2 (A), (B), (C) and (D) reveals DAVF being supplied by engorged left occipital artery from external carotid artery; (E) and
(F) the vein of Labbe´ and sigmoid sinus were patent.
Figure 3 (A) and (B) The vein of Labbe´ and sigmoid sinus were patent post-TAE; (C) post-TAE brain CT reveals hematoma with
perifocal edema in progress; (D) brain CT after 9 days of TAE; (E) and (F) the vein of Labbe´ and sigmoid sinus were occluded 9 days
post-TAE.
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We report the rare TAE complication of an intracranial DAVF.
Delayed venous infarcts can develop up to 10 days following
endovascular intervention with a DAVF. Blood flow redistri-
bution combined with a systemic hemodynamic change can
result in intracranial hemorrhage and venous infarcts. To
prevent this vascular complication, early recognition of late-
onset venous infarcts and the reversal of risk factors
contributing to CVT could be crucial. We suggest that thepostinterventional observation period beextended to at least
2 weeks for patients with predisposing factors for CVT.
References
1. Schaller B, Graf R. Cerebral venous infarction: the pathophysi-
ological concept. Cerebrovasc Dis. 2004;18(3):179e188.
2. Damak M, Crassard I, Wolff V, Bousser MG. Isolated lateral sinus
thrombosis: a series of 62 patients. Stroke. 2009 Feb;40(2):
476e481.
